1. Introduction {#sec0005}
===============

Porcine epidemic diarrhea virus (PEDV), a member of the genus *Alphacoronavirus* of the family *Coronaviridae* ([@bib0190], [@bib0255], [@bib0395]), was initially identified in Europe in 1978 as the causative agent of porcine epidemic diarrhea (PED), an acute, highly contagious, and severe enteric disease affecting swine ([@bib0365]). PED is characterized by severe diarrhea, vomiting, and dehydration followed by high mortality in suckling piglets (50--100%). Animals of all ages are susceptible to PEDV; however, older pigs usually present a milder form of the disease with lower mortality rates ([@bib0005], [@bib0010]).

Since its initial detection in Europe, PEDV has spread to several of the major swine producing areas of the world, including Asia and most recently North America, causing significant economic losses to the swine industry ([@bib0255], [@bib0395]). In Asia, the virus was first detected in Japan in 1982, spreading to several neighboring countries, including Korea, China, Thailand, Taiwan and Vietnam, where it remains endemic to date ([@bib0050], [@bib0255], [@bib0330], [@bib0425]). In 2013, PEDV was introduced in North America, being initially detected in the US and subsequently spreading to Canada and Mexico ([@bib0315], [@bib0415]). After its introduction in the US, PEDV was rapidly disseminated across the country, causing the deaths of over 7 million piglets (∼10% of the country's swine population).

The PEDV genome consists of a large (∼28 kb) single-stranded, positive sense RNA molecule that contains seven open reading frames (ORF1a, ORF1b, and ORF2-6). ORFs 1a and 1b encode large polyproteins (pp1a and pp1b), which are cleaved by viral encoded proteases into 16 non-structural proteins (nsp1-nsp16) involved in basic mechanisms of viral RNA transcription and replication ([@bib0255], [@bib0395]). ORFs2-6 encode four structural proteins, including the Spike (S) glycoprotein, membrane (M) protein, envelope (E) protein, and the nucleocapsid (N) protein, and one accessory protein ORF3 ([@bib0170], [@bib0255], [@bib0395]). Among the structural proteins, the S glycoprotein plays an important role in receptor binding, cell membrane fusion and entry, and is the main target of neutralizing antibodies against PEDV ([@bib0095], [@bib0420], [@bib0450]). Notably, the S gene has been frequently targeted in epidemiological studies involving phylogenetic analysis and in a number of molecular and serologic diagnostic assays for PEDV ([@bib0130], [@bib0170], [@bib0235], [@bib0265], [@bib0345], [@bib0360]). Additionally, the M and N proteins have been targeted for the development of molecular and serological diagnostic assays for PEDV ([@bib0175], [@bib0325], [@bib0450])

Outbreaks of watery diarrhea concurrent with high mortality rates in suckling piglets are usually the first signs that PEDV might be circulating within a swine population. However, given the similarities of these clinical manifestations with other enteric pathogens of swine, including the closely related coronaviruses, transmissible gastroenteritis virus (TGEV) and porcine deltacoronavirus (PDCoV) ([@bib0065], [@bib0215], [@bib0220], [@bib0405], [@bib0440]), a diagnosis of PEDV cannot be made based on the clinical signs and histological changes observed in the gastrointestinal tract. A positive PEDV diagnosis involves the detection and identification of PEDV-specific proteins or its RNA genome in clinical samples from affected animals. Conventional PEDV diagnostic methods are based on the detection of the virus, its nucleic acid, viral proteins or antibodies induced in response to infection. While the diagnosis of a PEDV outbreak is usually best obtained by virological detection methods, serological assays provide important information regarding previous exposure to the virus and the immune status of a given animal and/or herd. Here we present a brief overview of virological and serological diagnostic methods that allow rapid and accurate detection of PEDV and assessment of the host responses to infection.

2. PEDV infection dynamics and host responses to infection {#sec0010}
==========================================================

After fecal-oral transmission, PEDV replicates in epithelial cells lining the small intestine, resulting in rapid necrosis and destruction of infected cells ([@bib0205], [@bib0430]). Following an incubation period that varies from one day in 1-day-old nursing piglets to 3--6 days in 3-week-old weaned piglets, characteristic clinical signs of PED, including diarrhea and vomiting, are observed and usually persist for approximately 5--10 days ([@bib0205], [@bib0290], [@bib0285], [@bib0415]). Fecal shedding of PEDV occurs shortly after infection (1--3 days), and the virus RNA has been detected in feces for up to 24--30 days post-infection (pi) ([@bib0430]). A short viremic phase has been described between one and five days pi in suckling piglets ([@bib0205], [@bib0290]). Viral antigens have been detected in enterocytes in the duodenum and ileum as early as 12 h pi in 1-day old piglets ([@bib0290]), and through day 14 pi in 3-week-old weaned pigs ([@bib0285]).

Antibodies are first detected in serum between days 6 and 14 post-primary infection with PEDV ([@bib0325]). Notably, antibody responses generated against PEDV N and S proteins, the two major structural proteins of the virus, present different magnitude and dynamics ([Fig. 1](#fig0005){ref-type="fig"} ). While N-specific IgM antibodies peak on day 7 pi, S IgM responses peak on day 14 pi declining to pre-infection levels between days 14 and 21 pi. Whereas N- and S-specific IgG antibodies are first detected on day 7 pi, with anti-N IgG antibodies peaking on day 21 pi, and S IgG responses peaking on day 14 pi. Both N- and S-IgG antibody levels begin to decline around day 21 pi, whereas N IgG responses seem to be sustained for up to 43 dpi. Notably, S-specific IgA responses present a similar kinetics to S-IgG responses, with a low level of antibodies being detected on day 7, peaking on day 14 pi, with sustained levels for up to 6 months ([@bib0340]).Fig. 1Porcine epidemic diarrhea virus infection dynamics and host responses to infection. Schematic representation of the course of PEDV infection highlighting time of clinical signs, virus shedding in feces and the kinetics of serum antibody responses against the virus. N IgM: nucleoprotein specific serum IgM responses; N IgG: nucleocapsid specific serum IgG responses; S IgM: spike specific serum IgM responses; S IgG: spike specific serum IgG responses; S IgA: spike specific serum IgA responses; NAbs: serum neutralizing antibody responses. The information presented was collected from several PEDV experimental studies performed with naïve animals of different age groups. It is important to note that a short viremic phase (1--3 days) that has been described in neonatal piglets is not depicted in the graph.Fig. 1

PEDV specific antibodies have also been detected in oral fluids using IgG or IgA isotype ELISAs ([@bib0030], [@bib0140]). Notably, IgA seems to be the predominant antibody isotype in oral fluids, with antibody levels increasing through 100 days post-infection. While IgG antibody levels peaked around day 14 post-infection gradually declining thereafter ([@bib0030]).

Neutralizing PEDV antibodies (NAbs) are first detected between days 7 and 14 pi, peaking on day 21 pi ([@bib0340], [@bib0430]). Notably, NAbs seem to persist for at least 6 months post infection ([Fig. 1](#fig0005){ref-type="fig"}) ([@bib0085], [@bib0340]). These aspects of PEDV infection and host responses to the virus provide important information that should be considered prior to diagnostic sample collection and testing.

3. PEDV diagnosis {#sec0015}
=================

Current PEDV diagnostic assays can be divided in two categories: virological and serological methods. Virological methods target detection of the virus, its nucleic acid and viral proteins, while serological assays detect antibodies induced in response to infection. Following the introduction of PEDV in the US in 2013, a new array of improved diagnostic reagents and assays were developed for rapid and specific detection of PEDV. Here we present a brief overview of the properties of these assays. A summary of current PEDV diagnostic assays and their properties are presented in [Table 1](#tbl0005){ref-type="table"} .Table 1Properties of PEDV diagnostic assays.Table 1Assay CategoryAssayPrincipleAppropriate\
SamplesRelative Analytical Sensitivity[a](#tblfn0005){ref-type="table-fn"}ReferencesDetection of viable virusVirus\
isolationIsolation of infectious PEDV in cell cultureIntestine\
Intestinal contents+/−[b](#tblfn0010){ref-type="table-fn"}[@bib0060], [@bib0320]Detection of viral antigensIFDetection of PEDV antigens in cell culture or tissues using antibodiesCell culture\
Intestine+++[@bib0100], [@bib0200]IHCDetection of PEDV antigens using antibodies in tissuesIntestine+++[@bib0155]Ag ELISADetection/capture of PEDV antigens on a solid phase using a pair of antibodiesFeces+++[@bib0040], [@bib0045]Detection of viral RNART-PCRPrimer specific amplification of PEDV nucleic acidRectal swabs\
Feces\
Intestine\
Intestinal contents\
Oral fluid[c](#tblfn0015){ref-type="table-fn"}+++[@bib0175], [@bib0245]rRT-PCRPrimer specific amplification and fluorescent probe-based detection of PEDV RNA+++++[@bib0230], [@bib0295], [@bib0460]LAMP-RT-PCRIsothermal amplification of PEDV RNA using specific primers+++[@bib0375], [@bib0465]Detection of host antibody responsesVN/FFN[d](#tblfn0020){ref-type="table-fn"}Detection of antibodies capable of neutralizing PEDV infectivitySerum++[@bib0085], [@bib0325]IFADetection of serum antibodies tested in PEDV infected cell culture++[@bib0325], [@bib0085], [@bib0430]iELISA[e](#tblfn0025){ref-type="table-fn"}Two-step detection of serum antibodies with antigen immobilized into a solid phase and anti-swine secondary antibody+++[@bib0325], [@bib0265]bELISACompeting antibody mixed with serum and compete for antigen on the solid phase+++[@bib0045], [@bib0325]FMIADetection of PEDV antibodies by antigen coupled to fluorescent beads+++[@bib0325][^1][^2][^3][^4][^5]

3.1. Virological assays for the detection of PEDV and/or viral antigens {#sec0020}
-----------------------------------------------------------------------

### 3.1.1. Virus isolation {#sec0025}

Vero cells are the most widely used cell line for isolation and propagation of PEDV ([@bib0060], [@bib0190], [@bib0320]). Typical cytopathic effect (CPE) induced by PEDV replication in cell culture is characterized by cell fusion, syncytia formation and eventually cell detachment ([@bib0060], [@bib0320]) ([Fig. 2](#fig0010){ref-type="fig"} ). Isolation of PEDV in cell culture is usually confirmed by immunofluorescence ([Fig. 2](#fig0010){ref-type="fig"}) and/or RT-PCR ([@bib0060], [@bib0320]).Fig. 2Isolation of PEDV in cell culture. (A) Cytopathic effect characterized by syncytia and cell detachment induced by PEDV isolate SD15-134 in Vero cells at 48 h post-infection (passage 2). (B) Immunofluorescence confirming isolation of PEDV isolate SD15-134 in Vero cells at 48 h pi (anti-PEDV N protein MAb SD6-29-FITC).Fig. 2

Replication of PEDV in cell culture is dependent on the presence of exogenous trypsin in the cell culture medium ([@bib0060], [@bib0320], [@bib0450]). The proteolytic activity of trypsin leads to cleavage of the S glycoprotein into the S1 and S2 subunits, resulting in enhanced virus-to-cell and cell-to-cell fusion and increased virus infectivity and release from infected cells ([@bib0450]). Therefore, exogenous trypsin has to be added to the medium for isolation of PEDV in cell culture.

The dependence on exogenous trypsin and the lack of a better cell culture system, make the isolation of PEDV in cell culture difficult. Two recent studies undertook a comprehensive approach to optimize the isolation of PEDV in cell culture ([@bib0060], [@bib0320]). However, from a total of 138 clinical samples that were positive for PEDV by RT-PCR, only 13 PEDV isolates were recovered in Vero cells ([@bib0060], [@bib0320]). All these isolates were obtained from intestinal contents ([@bib0320]) or intestinal homogenates ([@bib0060]), and no virus was recovered from rRT-PCR positive fecal samples ([@bib0060]). Recently, however, Chen and collaborators ([@bib0070]) reported the isolation of three PEDV strains from rRT-PCR fecal samples. These observations indicate a low diagnostic sensitivity of PEDV isolation methods, and highlight the need for improved cell culture systems for the isolation PEDV *in vitro*. Primary intestinal epithelial cell cultures or cell lines expressing the PEDV receptor, porcine aminopepidase N (APN) ([@bib0260], [@bib0300], [@bib0390]), could be valuable alternatives and potentially increase the success rate of PEDV isolation in cell culture ([@bib0280]).

### 3.1.2. Immunofluorescence assay (IF) {#sec0030}

The immunofluorescence (IF) assay has been used to detect PEDV antigens in cell culture to confirm virus isolation ([@bib0060], [@bib0320]), or in cryosections of intestinal tissue to detect virus antigens in infected enterocytes ([@bib0100], [@bib0155], [@bib0190], [@bib0200]). The principle of the assay consists of the immune-detection of viral antigens (antibody-antigen reaction) in cell culture or ultrathin cryosections of tissues from pigs suspected of being infected with PEDV. Intracellular viral antigens are detected using fluorophore-conjugated PEDV-specific antibodies. Fluorescent viral antigens are visualized in the cytoplasm of infected cells under a fluorescent microscope. PEDV antigens have been detected by IF in villous epithelial cells throughout the small intestine during various stages of infection, including at early stages involving the incubation period of the disease (first 12--24 h pi). Viral antigens have been detected in intestinal samples for up to 72 h after the onset of clinical signs by the IF assay ([@bib0100], [@bib0155], [@bib0200]).

### 3.1.3. Immunohistochemistry (IHC) {#sec0035}

Immunohistochemistry (IHC) has been used for the detection of PEDV antigens in intestinal tissues ([Fig. 3](#fig0015){ref-type="fig"} ) ([@bib0155], [@bib0210], [@bib0290], [@bib0415]). IHC is based on the detection of PEDV antigens in tissue sections by means of immunological (antibody-antigen) and chemical (enzyme-substrate) reactions ([@bib0370]). Viral antigens are detected using PEDV-specific antibodies that are subsequently detected using an enzyme-linked secondary antibody followed by chemical substrate development ([@bib0155], [@bib0370]). Similar to the results obtained via IF, PEDV antigens have been detected by IHC prior to the development of clinical signs (1 day pi) and up to day 14 pi ([@bib0155], [@bib0290]). The major advantage of using *in situ* detection methods such as IF and IHC for the diagnosis of PEDV is that they allow the visualization of target cells and the tissue distribution of viral antigens during the course of infection ([@bib0115]). Additionally, IHC is performed in formalin fixed paraffin-embedded tissues, which allows long-term storage and retrospective testing of archived tissue samples.Fig. 3Immunohistochemistry detection of PEDV antigens in small intestine epithelial enterocytes. Brown staining indicates PEDV N antigen in the cytoplasm of infected enterocytes (right panel). Antigen was detected with anti-N protein MAb SD6-29 followed by development with chromogenic substrate. Left panel: negative control.Fig. 3

### 3.1.4. Antigen ELISA {#sec0040}

Porcine epidemic diarrhea virus (PEDV) antigens can be detected in feces using antigen capture ELISAs ([@bib0040], [@bib0045], [@bib0380]). PEDV antigen capture or sandwich ELISAs are based on the use of a pair of PEDV-specific antibodies to capture and detect virus antigens onto a solid phase ([@bib0020], [@bib0040], [@bib0045], [@bib0380]). The solid phase (polystyrene, polyvinyl or polypropylene microplate well) is coated with the PEDV-specific capture antibody and incubated with the sample, when the PEDV antigens present in the sample bind the capture antibody. The detecting antibody will bind to the virus antigen, and the reaction is developed by adding an enzyme-linked secondary antibody, followed by a chemical substrate ([@bib0020]). PEDV capture ELISAs have been developed for detection of PEDV in fecal samples ([@bib0040], [@bib0380], [@bib0410]); however, detection of the virus in clinical samples may be affected by several factors ([@bib0380]), including the timing of sample collection and the conditions of sample storage and shipping to the laboratory (*i.e*. temperature) ([@bib0185], [@bib0380]). Fecal shedding of PEDV, for example, was consistently detected by antigen capture ELISA during the acute phase of the disease, but much less frequently during the incubation period or the recovery phase ([@bib0040], [@bib0410]). It is advisable, therefore, that samples are collected during the acute phase of infection, shortly after the onset of the clinical signs ([@bib0410]), and shipped on ice to the laboratory ([@bib0185]).

3.2. Polymerase chain reaction (PCR)-based assays for detection of PEDV nucleic acid {#sec0045}
------------------------------------------------------------------------------------

Given the diagnostic sensitivity and specificity and rapid turnaround of results, molecular diagnostic assays, such as conventional and real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) assays, became the methods of choice for the diagnosis of PEDV ([@bib0150], [@bib0230], [@bib0400], [@bib0480]). Most veterinary diagnostic laboratories in the US, report rRT-PCR results within 24 h of receiving the clinical samples, thus, allowing for rapid implementation of intervention and control measures to reduce the risk of further dissemination of the virus.

PCR-based assays can be applied to detect the PEDV genome in feces, rectal swabs or intestinal samples from animals suspected of being infected with the virus ([@bib0060], [@bib0205]). Additionally, oral fluid has been routinely used for diagnosis of PEDV infection ([@bib0030], [@bib0140]), and feed samples have been used on rRT-PCR based epidemiological investigations for PEDV ([@bib0035], [@bib0105], [@bib0135], [@bib0350], [@bib0385], [@bib0460]). PCR-based assays provide more sensitive, specific and rapid alternatives to virus isolation or other antigen detection methods, such as IF, IHC and antigen capture ELISA; however, since the PCR detects the viral nucleic, it may be positive when no infectious virus is present in the clinical sample.

When designing primers for detection of PEDV, it is important to select areas of the virus genome that allow the detection of most PEDV strains circulating in the field (*i.e*. PEDV prototype, S-indel) ([@bib0320]), and the differentiation from other closely related viruses, including TGEV and PDCoV. Most PCR based assays for PEDV have been designed against the genes encoding one of the structural proteins of the virus, N, M or S ([@bib0025], [@bib0175], [@bib0195], [@bib0295], [@bib0400], [@bib0480]). While these genes represent good diagnostic targets, it is important to consider their genetic variability ([@bib0180]) when designing new assays. The S gene, for example, has been shown to be one of the most variable regions of PEDV genome ([@bib0055], [@bib0180]), with several variant strains containing deletions in the S1 region being reported in the US and in China ([@bib0180], [@bib0320], [@bib0470]). Therefore, it is important to conduct extensive testing of all new PCR-based assays intended for use in PEDV diagnosis ([@bib0295]). A summary of recent PCR-based assays developed for the detection of PEDV is presented in [Table 2](#tbl0010){ref-type="table"} .Table 2Summary of rRT-PCR assays for PEDV diagnosis.[a](#tblfn0030){ref-type="table-fn"}Table 2Detection methodTargetAnalytical Sensitivity[b](#tblfn0035){ref-type="table-fn"}ReferenceRT-PCRM protein10^1^ TCID~50~/mL[@bib0215], [@bib0220]S protein10^1^ TCID~50~/mL[@bib0225]  rRT-PCR10^−2.2^ TCID~50~/mL[@bib0295]N protein--[c](#tblfn0040){ref-type="table-fn"}[@bib0350]4.8 log~10~ (feces) and 3.8 log~10~ (serum) GE/mL[@bib0200]1 TCID~50~/mL[@bib0230]S protein10^−0.2^ TCID~50~/mL[@bib0295]5 × 10^2^ DNA copies/μL[@bib0480]2.1 × 10^3^ DNA copies/μL[@bib0475]M and S proteins1 DNA copy/μL[@bib0440], [@bib0445]  LAMP-RT-PCRM protein10^−1^ TCID~50~/mL[@bib0465]N protein(10^0.75^ TCID~50~/mL)[@bib0375][^6][^7][^8]

### 3.2.1. Conventional RT-PCR {#sec0050}

Several conventional RT-PCR assays have been developed for the detection of PEDV ([@bib0175], [@bib0245], [@bib0250]). These assays consist of the amplification of a target region of the PEDV genome using virus specific primers in RT-PCR reactions, followed by electrophoresis and visualization of amplicons in agarose gels ([@bib0175], [@bib0245], [@bib0250]). A few studies have also described the development of multiplex RT-PCR assays for detection and differentiation of several porcine enteric viruses, including PEDV, TGEV and porcine rotaviruses (group A) ([@bib0025], [@bib0110], [@bib0195], [@bib0215], [@bib0220]). These assays have now mostly been replaced by more sensitive and rapid real-time RT-PCR assays (rRT-PCR).

### 3.2.2. Real-time RT-PCR (rRT-PCR) {#sec0055}

There are two common methods for the detection of amplicons in rRT-PCR: (1) non-specific fluorescent dyes that intercalate with double-stranded DNA, and (2) sequence-specific oligonucleotide probes that are labeled with a fluorescent reporter allowing the detection after hybridization of the probe with its target sequence ([@bib0015]). Given the higher diagnostic specificity of probe-based assays, they are usually the best choice for molecular diagnostics. The increase in fluorescence emission by the fluorescent probe during extension of the target sequence is detected in real time by the thermocycler ([@bib0015]).

The major advantages of rRT-PCR assays are the analytical sensitivity and the ability to detect the target sequences simultaneously with the amplification reaction ([@bib0015]). Additionally, rRT-PCR assays allow high throughput testing and process automation. Another advantage of the rRT-PCR is its multiplexing capability, which allows simultaneous testing and discrimination of different strains of PEDV ([@bib0480]) or of other enteric viral pathogens of swine, including the closely related coronaviruses TGEV and PDCoV ([@bib0230], [@bib0400], [@bib0480]). Recently, a multiplex rRT-PCR assay developed for simultaneous detection of PEDV, TGEV, group A rotaviruses, and porcine circovirus 2 (PCV2) revealed that PEDV is the most common viral cause of enteric infections in China (42.1%), whereas the most common co-infection found in the study involved PEDV and PCV2 (9%) ([@bib0480]). This study is a clear example of the utility and versatility of multiplex rRT-PCR assays for the diagnosis of enteric infections in swine.

After the introduction of PEDV in the US in 2013 ([@bib0060], [@bib0415]), several PCR-based assays were developed for the diagnosis of PEDV infection ([@bib0415]). Initially, gel-based PCR assays were used; however, these were quickly replaced by more sensitive and high throughput rRT-PCR assays ([@bib0445]). With the introduction of PDCoV in the US swine population in 2014 ([@bib0440]), multiplex rRT-PCR assays were developed to allow simultaneous testing and discrimination between the two swine enteric coronaviruses. At the SDSU Animal Disease and Research Diagnostic Laboratory (ADRDL), for example, a multiplex rRT-PCR assay for simultaneous detection of PEDV, PDCoV and TGEV has been used routinely since July 2014. Since then, approximately 22,000 samples from about 25 US states have been tested using this multiplex assay. Of these 12% were positive for PEDV, 2.2% were positive for PDCoV and 1.8% were positive for both PEDV and PDCoV. No TGEV positive samples were detected from July 2014 to March 2016. A summary of the multiplex rRT-PCR results for individual years (2014, 2015 and 2016) is presented in [Fig. 4](#fig0020){ref-type="fig"} . Notably, similar cumulative detection rates are observed at national level, with 12.3% of accessions tested since 2014 being positive for PEDV and 2.2% testing positive for PDCoV ([www.aphis.usda.gov/animal-health/secd](http://www.aphis.usda.gov/animal-health/secd){#intr0005}).Fig. 4Multiplex rRT-PCR results for PEDV, PDCoV and TGEV. Results represent clinical samples submitted to routine diagnostic investigation at the SD ADRDL between July 2014 and March 2016. Overall percentage of rRT-PCR positive samples are presented on the plots on the left (green) and individual percentages for PEDV (orange), and PDCoV (gray), or co-infection with PEDV plus PDCoV (golden yellow) are presented on the plots on the right. Not detected: rRT-PCR assay was negative for all three pathogens (PEDV, PDCoV and TGEV).Fig. 4

Many other rRT-PCR assays have been developed for the diagnosis of PEDV by research groups around the world, and both diagnostic and analytical sensitivity and specificity of these assays have been extensively evaluated using experimental and/or clinical samples ([@bib0230], [@bib0295], [@bib0445], [@bib0480]). Recently, Miller and collaborators evaluated two rRT-PCR assays targeting the N and the S gene of PEDV ([@bib0295]). The detection limit of these rRT-PCRs were 10^−6^ and 10^−5^ for the N and S assays, which corresponds to a virus suspension containing ∼10^−2.2^ and ∼10^−0.2^  TCID~50~/mL of PEDV, respectively ([@bib0295]). Additionally, from a total of 1064 fecal swabs that were subjected to these rRT-PCR assays, 354 samples tested positive by the N assay, while 349 were positive by the S assay, indicating a slightly better performance of the N-based assay. Interestingly, by inoculating 3-day-old piglets with a serial dilution of PEDV with known Cq values, the authors were able to determine the infectious dose of the virus (10^1.3^ and 10^2.3^ TCID~50~/mL) and correlate it to the Cq values obtained by the N rRT-PCR assay (24.14 \[±0.02\] and 27.28 \[±0.07\], respectively) ([@bib0295]).

In addition to rRT-PCR assays developed by research groups and diagnostic laboratories, multiple commercial kits were developed and are currently available, including the multiplex assay for PEDV, TGEV and PDCoV used at the SD ADRDL (EZ-PED/TGE/PDCoV MPX 1.0; Tetracore Inc., Rockville, MD). These assays represent important tools for rapid and accurate detection of PEDV infection.

### 3.2.3. Isothermal amplification assays {#sec0060}

Loop-mediated isothermal amplification (LAMP) is a simple, specific and cost-effective nucleic acid amplification method ([@bib0305]), that has been recently applied for infectious disease diagnosis, including for the detection of PEDV ([@bib0305], [@bib0375], [@bib0465]). The assay uses four to six primers that recognize six to eight regions of target DNA in association with the Bst DNA polymerase, which presents strand-displacement activity ([@bib0305], [@bib0375]). The synchronized binding of the primers to the target sequences maintains the specificity of the assay ([@bib0305], [@bib0375]). Notably, the amplification step can be performed under a single temperature (isothermal conditions), resulting in the synthesis of large amounts of nucleic acid ([@bib0305], [@bib0375]). The amplification reactions can be performed using inexpensive equipment (*i.e*. water bath), without the need for thermocyclers ([@bib0305], [@bib0335]). Furthermore, the addition of a fluorescent dye in the reaction mix allows the assessment of the results by simple visual inspection ([@bib0435]). To date, two isothermal amplification assays have been designed and evaluated for the diagnosis of PEDV ([@bib0375], [@bib0465]).

The RT-LAMP developed by Ren and Li ([@bib0375]) was designed to amplify the N gene of PEDV. The analytical sensitivity of the assay was assessed with experimental samples and compared to the sensitivity of a conventional RT-PCR assay and an antigen capture ELISA. The detection limit of the RT-LAMP was lower than that of the RT-PCR (10^0.75^ *vs* 10^2.25^ TCID~50~/mL, respectively), and that of the antigen capture ELISA (1 × 10^−3^  μg PEDV particles *vs* 1 × 10^−4^  μg PEDV particles). Comparisons among all three assays in clinical samples revealed similar diagnostic sensitivity and specificity ([@bib0375]).

Recently Yu and collaborators developed and optimized a real-time RT-LAMP (rRT-LAMP) for the detection of PEDV ([@bib0465]). In this study the authors evaluated five sets of primers targeting the M gene of PEDV. They have used a loopamp real-time turbidimeter to detect the amplification of the target sequence. The analytical sensitivity of the assay was determined and compared to a conventional and a real-time RT-PCR by testing 10-fold serial dilutions of a viral stock containing a known amount of PEDV. The detection limits of the rRT-LAMP and the rRT-PCR were identical with both assays detecting 10^−1^  TCID~50~/mL, whereas the detection limit of the conventional RT-PCR was 100-fold higher (10^1^  TCID~50~/mL) than the other two assays. The diagnostic and analytical sensitivity and specificity of RT-LAMP-based assays coupled with their low cost and efficiency make this method an alternative for PEDV diagnosis, if thermal cyclers or real-time instrumentation are not available ([@bib0465]).

3.3. Serological assays for detection of PEDV specific antibodies {#sec0065}
-----------------------------------------------------------------

Several assays have been developed for the detection of antibodies against PEDV in serum, colostrum, milk, feces and oral fluid including indirect fluorescent antibody assay (IFA), virus neutralization assays, enzyme-linked immunosorbent assay (ELISA), and fluorescent microsphere immunoassay (FMIA) ([@bib0125], [@bib0265], [@bib0325], [@bib0380]). Serological assays represent important tools to evaluate antibody responses to PEDV infection, to determine prior exposure of a given herd to the virus, or yet to evaluate the efficacy of vaccines and vaccination strategies. Detection of PEDV specific antibodies is also used to assess sow immunity, which might be helpful in predicting neonatal protection. To date, only one serotype of PEDV has been identified and current serological assays for PEDV have been shown to detect antibodies against various PEDV strains, including historical and contemporary prototype and S-indel strains ([@bib0075], [@bib0270]). Notably, cross reaction between hyperimmune serum generated against TGEV strain Miller and four strains of PEDV was observed in IFA assays; however, no cross neutralizing activity was detected ([@bib0075], [@bib0270]). In the following sections, we present a brief overview of the serological assays currently available for PEDV.

### 3.3.1. Indirect immunofluorescence assay (IFA) {#sec0070}

Indirect immunofluorescence assay (IFA) has been routinely used to detect antibodies against PEDV and to evaluate the immune status of affected herds ([@bib0285], [@bib0430]). The IFA assay is based on an antibody-antigen reaction. Usually, PEDV infected Vero cell cultures are used as antigen substrates to detect antibodies present in serum samples from suspect animals. If the sample is positive, the PEDV specific antibodies bind to the antigens immobilized in the solid phase. In a second step, these antibodies are detected with fluorophore-labeled anti-porcine secondary antibodies and visualized under a fluorescence microscope ([@bib0430], [@bib0085]). The IFA assay presents specificity comparable to ELISA and FFN assays and has the advantage of being less time consuming and easier to perform ([@bib0255]). IFA can also be used for qualitative (positive or negative) or quantitative (antibody titer) evaluation of PEDV-specific antibodies in serum. To determine the titers of antibodies, serial two-fold dilutions of serum are incubated with PEDV infected cells, and the antibody titers are determined as the reciprocal of the highest dilution of serum in which specific fluorescent signal is observed. PEDV-specific antibodies are first detected by IFA by 7--14 days post-exposure, and titers seem to be maintained for at least 43 days pi when a decline in the detectable levels of antibodies is observed. Despite being a useful assay for detection of antibodies during the acute stage of infection, the IFA is not the test of preference to determine prior exposure to PEDV due to the lower analytical sensitivity of the assay. Additionally, interpretation of endpoint IFA antibody titers is more subjective than other PEDV antibody detection assays.

### 3.3.2. Virus neutralization assays {#sec0075}

Virus neutralization assays (VNs) are widely used for detection of PEDV specific antibodies ([@bib0325]). Virus neutralization is defined as the reduction in viral infectivity mediated by antibodies (neutralizing antibodies \[NAbs\]) ([@bib0240]). By binding to the virions, NAbs block one or more steps of the viral replication cycle (*i.e*. entry, binding to cellular receptors, uncoating), and/or cause aggregation or lysis of virus particles, thus neutralizing or reducing virus infectivity ([@bib0240]). Historically, CPE-based VNs have been used to detect NAbs against PEDV ([@bib0355], [@bib0360]). However, interpretation of endpoint neutralization titers based on CPE is complicated by the fact that the trypsin added in the culture media leads to cell rounding and detachment, thus impairing precise differentiation between virus- and trypsin-induced changes in cellular morphology ([@bib0325]).

Recently, neutralization assays using a fluorescent focus neutralization (FFN) format have been developed for PEDV ([@bib0325], [@bib0430]). The FFN allows for rapid assessment of NAbs titers (∼30 h) against PEDV, because viral antigens can be detected earlier than virus induced CPE in infected cells. To detect the presence of PEDV neutralizing antibodies using the FFN assay, serial dilutions of serum samples are incubated with a constant amount of PEDV, thus allowing the antibodies to bind to the virus. The antibody-virus mixture is transferred to susceptible Vero cell cultures and PEDV infectivity is assessed by using an anti-PEDV fluorophore-conjugated antibody ([@bib0325], [@bib0430]). NAb titers are determined as the reciprocal of the highest serum dilution resulting in 90% or greater reduction in fluorescent foci relative to negative control samples ([@bib0325]). Neutralizing antibodies against PEDV have been detected by day 7--14 pi ([@bib0325], [@bib0430]) in experimentally infected animals, with high titers of NAbs being detected for at least six months post-natural infection ([@bib0085], [@bib0340]).

The FFN assay has also been optimized for the detection and quantitation of PEDV NAbs in colostrum and milk samples ([@bib0085], [@bib0325]). This is important to monitor the transfer of maternal immunity to suckling piglets. The levels of NAbs detected in colostrum are higher (four-fold) than those detected in serum. Whereas, levels of NAbs detected in milk are similar to those detected in serum ([@bib0085], [@bib0325]). Given that VN or FFN assays detect functional antibodies capable of neutralizing PEDV infectivity, these assays have been frequently used in studies evaluating novel vaccine candidates for PEDV ([@bib0090], [@bib0145], [@bib0275], [@bib0355]). Additionally, NAbs are very specific, and VN assays are capable of discriminating between serologic responses induced against PEDV and the closely related TGEV ([@bib0075], [@bib0270]).

### 3.3.3. ELISAs {#sec0080}

Two types of ELISAs have been used for the detection of antibodies against PEDV, including the indirect ([@bib0120], [@bib0125], [@bib0130], [@bib0160], [@bib0165], [@bib0265], [@bib0325]) and the competitive or blocking-ELISA ([@bib0045], [@bib0325], [@bib0455]). The indirect ELISAs have been developed based on either whole virus preparations ([@bib0160], [@bib0310], [@bib0430]) or recombinant viral proteins (S, N and M) expressed in bacteria ([@bib0125], [@bib0130], [@bib0165], [@bib0265], [@bib0325], [@bib0360]). In this assay, the viral antigen is immobilized on a solid polystyrene surface, and incubated with the test sample to allow the antibody-antigen complex to form. The reaction is developed by using an enzyme-linked secondary antibody coupled with a colorimetric substrate ([@bib0020]).

The PEDV blocking or competitive ELISAs are based on the use of PEDV-specific monoclonal or polyclonal antibodies ([@bib0045], [@bib0325], [@bib0455]) that, when added to the antigen coated microplates together with the test sample, compete with the antibodies present in the serum for the antigen immobilized in the wells ([@bib0020]). The reaction is developed as described above for the indirect ELISA, with the addition of an enzyme-linked secondary antibody followed by an enzyme-substrate colorimetric reaction. The main advantage of the blocking ELISA is its increased specificity when compared to the indirect ELISA ([@bib0020]); however, the assay specificity seems to be dependent on the isotype of the blocking antibody and its specificity for the target antigen ([@bib0045]).

Recently, the SDSU ADRDL developed several serological assays for the detection of antibodies against PEDV, including an indirect and a blocking ELISA based on the N protein ([@bib0325]). These have been evaluated using experimental and clinical samples and presented similar diagnostic sensitivity and specificity (97.9 and 97.6% for the iELISA; and 98.2 and 98.0% for the bELISA, respectively) ([@bib0325]). Both assays detected N-specific IgG antibodies between days 9 and 14 pi, with peak antibody levels being detected on day 21 pi. On day 43 pi, N-specific antibodies were still detected by both assays; however a slight decline in the antibody levels was observed after day 21 pi ([@bib0325]).

Indirect ELISAs have been recently developed to assess the presence of PEDV-specific IgG and IgA antibodies in oral fluids ([@bib0030], [@bib0140]). Notably, levels of PEDV specific IgA antibodies in oral fluid seem to increase through ∼100 days post-infection ([@bib0030], [@bib0140]). This observation makes oral fluid a good sample to monitor prior herd exposure to PEDV.

### 3.3.4. Fluorescent microsphere immunoassay (FMIA) {#sec0085}

The fluorescent microsphere immunoassay (FMIA) is based on a fluidic fluorescent microsphere laser scanning system that has several advantages over the ELISA, including analytical sensitivity, higher sample throughput, and the ability to multiplex and detect antibodies to multiple pathogens simultaneously ([@bib0080]). The FMIA is based on coupling a specific viral antigen to fluorescent microspheres; then, antigen-specific antibodies are detected using a biotin/streptavidin/fluorophore detection system. Antigen-antibody reactions are detected using dual-laser instruments (*i.e*. Bio-Plex 200, Bio-Rad) and results expressed as median fluorescent intensity (MFI) ([@bib0325]).

Recently, a FMIA based on the N protein of PEDV was developed for the detection of PEDV specific antibodies in serum ([@bib0325]). This assay was evaluated using a large number of experimental and clinical samples and the results obtained by the FMIA presented a high correlation with those obtained by indirect and blocking ELISAs and by the IFA test (kappa scores \>0.91) ([@bib0325]). Additionally, diagnostic sensitivity and specificity were 98.2% and 99.2%, respectively ([@bib0325]). PEDV N-specific antibodies were detected as early as 6 days pi, peaking on day 21 pi and being detected up to day 43 pi ([@bib0325]).

4. Conclusions {#sec0090}
==============

Rapid and accurate diagnosis of PEDV infection are critical for the implementation of effective disease control measures. Thus, reliable virological and serological diagnostic assays are extremely important. While virological tests allow the rapid identification of PEDV and its differentiation from other enteric pathogens of swine, serological assays provide valuable information regarding prior exposure to PEDV and the prevalence of infection. Additionally, serological screenings allow the evaluation of novel vaccines and vaccination strategies in the field. Immunoassays such as ELISAs and FMIAs also allow the evaluation of isotype-specific immune responses against PEDV. The introduction of PEDV in the US in 2013 and its re-emergence in Asia have resulted in the development of a broad array of improved diagnostic assays to detect the virus or to evaluate the host responses to infection. As more reagents become available (*i.e*. monoclonal antibodies against S, N and M), we are likely to see the development of additional diagnostic approaches that may allow rapid on-site diagnosis of PEDV.

We thank all staff at the SD ADRDL that have contributed to this work through routine diagnostic assay development and testing. We also thank funding agencies such as NIFA-USDA Hatch and National Pork board for their support towards this work.

[^1]: Relative analytical sensitivity based on comparison with other assays in the same category. Increased number of + represents increased assay sensitivity.

[^2]: VI has a very low sensitivity as shown in [@bib0060] and [@bib0320].

[^3]: Typically tested by rRT-PCR.

[^4]: NAbs can also be detected in colostrum and milk samples.

[^5]: Has been used to detect antibodies in oral fluid.

[^6]: Assays shown represent only a fraction of the PCR-based assays for PEDV.

[^7]: Sensitivity units were obtained from original article describing each assay.

[^8]: No sensitivity data available.
